Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axcelead, Inc.
Minato-ku, Tokyo, Japanaxcelead-us.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Preclinical
01
Overview
Axcelead, founded as a Takeda Pharmaceutical spin-out in July 2017, operates as Japan’s first comprehensive integrated drug discovery solutions provider. It offers end-to-end R&D services spanning small molecules, cell therapies, immune-oncology agents, targeted protein degraders via its proprietary DegLead platform, and mRNA pharmaceuticals through its CDMO subsidiary ARCALIS. The company collaborates with major pharma companies such as Astellas Pharma to advance innovative therapeutics using advanced screening technologies and AI-driven platforms. Its business model focuses on co-development partnerships rather than developing its own clinical pipeline assets.
- Therapeutic areas
- Other
- Modalities
- Small moleculesCell therapyImmune-oncology agentsmRNA pharmaceuticalsTargeted protein degraders
- Industry
- Drug Discovery Services
02
Partnerships
Astellas Pharma – collaboration for targeted protein degrader compound discovery using DegLead Platform
Beyond the preview
Go deeper on Axcelead, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axcelead, Inc..